Skip to main
ATHA
ATHA logo

Athira Pharma (ATHA)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Athira Pharma (ATHA) Stock

About Athira Pharma (ATHA)

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Market cap$16.98M
Yesterday's volume270.83K
Revenue (TTM)
Avg. daily volume599.69K
EBITDA (TTM)-$77.65M
Open$0.44
Price / earnings ratio-0.21x
Yesterday's range$0.41 - $0.44
Debt / equity2.99x
52 week range$0.22 - $3.67
5 year debt / equity0.85x
Beta (LTM)1.27x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio7.26x
Ex-dividend date
Next earningsJul 31, 2025
Dividend payable date

Athira Pharma Stock Rating

What analysts recommend for ATHA stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 38%
Buy 13%
Hold 50%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 11, 2025, the market cap for ATHA stock is $16.98M

The current P/E ratio for ATHA stock is -0.21

The 52-week high for ATHA stock is $3.67. The current ATHA stock price $undefined is 100.00% below its 52-week high

The 52-week low for ATHA stock is $0.22. The current ATHA stock price $undefined has increased 100.00% from its 52-week low

No, the ATHA stock does not pay dividends to its shareholders

The target price for ATHA stock is $13.56 based on the average of what a group of analyst think ATHA stock could be worth at a future date. This is not a prediction by Public.com

How to buy ATHA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ATHA stock

    Navigate to the Explore page. Then, type ATHA into the search bar. When you see ATHA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ATHA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Athira Pharma Stock Earnings

The value each ATHA share was expected to gain vs. the value that each ATHA share actually gained.

Athira Pharma (ATHA) reported Q4 2024 earnings per share (EPS) of -$0.39, beating estimates of -$0.53 by 26.42%. In the same quarter last year, Athira Pharma's earnings per share (EPS) was -$0.71. Athira Pharma is expected to release next earnings on 07/31/2025, with an earnings per share (EPS) estimate of -$0.18.

Buy Athira Pharma (ATHA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.